researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial ...

Phase 1 results of a next-generation treatment targeting KRAS G12C, the cause of lung cancer, colon cancer, and pancreatic ...

We look forward to supporting innovation in the life science industry by continuing to deliver effective risk transfer ...

Headquartered in Apex, NC, Flourish's network of 27 sites and over 152 investigators conducts studies spanning all phases of clinical trial research. The Company is known for deep medical ...